Immunocore Holdings IMCR
NASDAQ IMCR
$36.43 -1.14 (-3.03%)
As of: Sep 4, 2026 · 2:25 PM EDT

Immunocore Holdings (IMCR) EPS (Diluted) (2021 - 2026)

Analysis

Immunocore Holdings (IMCR) EPS (Diluted) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Immunocore Holdings 1.86 Bn 976.76 Mn 114.84 Mn -0.02
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.02
Mar 31, 2026 0.25
Dec 31, 2025 -0.60
Sep 30, 2025 0.00
Jun 30, 2025 -0.20
Mar 31, 2025 0.10
Dec 31, 2024 -0.48
Sep 30, 2024 0.17
Jun 30, 2024 -0.23
Mar 31, 2024 -0.49
Dec 31, 2023 -0.40
Sep 30, 2023 0.02
Jun 30, 2023 -0.36
Mar 31, 2023 -0.40
Dec 31, 2022 -0.65
Sep 30, 2022 0.17
Jun 30, 2022 -0.46
Dec 31, 2021 -1.25
Sep 30, 2021 -1.57